The goals of a Phase 2 clinical trial are to determine if the treatment is effective and to gather more safety data. Researchers use the data from Phase 2 trials to refine their research questions ...

Phase 1 Trials There is little ethical discourse and few publications of phase 1 trials involving healthy volunteers. [17, 18] Phase 1 clinical trials are the gatekeepers for all clinical research.

Key Facts Clinical trials move through four structured phases, from safety testing to long-term effects. Adaptive, basket, and umbrella trials are making cancer research faster and more flexible.

A new tuberculosis (TB) vaccine candidate, M72/AS01E, has entered Phase III clinical trials, with Kenyans among the 20,000 ...

Q2 2025 Management View Brian Lian, President and CEO, reported that "the Viking team continued to focus on execution of our core clinical strategy," emphasizing advancement of both oral and ...

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1 clini ...

About Flourish Research Headquartered in Apex, NC, Flourish's network of 26 sites and over 150 investigators conducts studies spanning all phases of clinical trial research.

LOS ANGELES-- (BUSINESS WIRE)-- Pelage Pharmaceuticals, a clinical-stage regenerative medicine company, today announced positive results from its Phase 2a clinical trial of PP405 — a topical ...

TherVacB, a novel therapeutic vaccine for chronic hepatitis B developed under the leadership of Helmholtz Munich, has entered its first clinical trial in patients. Following a successful phase 1a ...

VCU Massey Comprehensive Cancer Center is the first site in the United States to be activated in a global Phase 2a clinical ...

The successful completion of phases one through five of Nexalin’s virtual clinic infrastructure positions the Company to further expand research collaborations, advance regulatory approvals, and ...

The Company plans to extend its Phase II trial of HT-001 in Cancer Patients with skin toxicities in European Union (EU) Countries NEW YORK, July 29, 2025 /PRNewswire/ ...